Abstract
Tyrosine kinase inhibitors (TKIs)-treatments bring significant benefit for patients harboring epidermal growth factor receptor (EGFR) mutations, espec......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
